Literature DB >> 24383100

The prevalence of undiagnosed and unrecognized primary hyperparathyroidism: a population-based analysis from the electronic medical record.

Danielle M Press, Allan E Siperstein, Eren Berber, Joyce J Shin, Rosemarie Metzger, Rosebel Monteiro, Jeff Mino, Warren Swagel, Jamie C Mitchell.   

Abstract

BACKGROUND: The electronic medical record (EMR) of a large, tertiary referral center was examined to study the prevalence of undiagnosed and unrecognized primary hyperparathyroidism (PHPT).
METHODS: The EMR was queried for outpatient serum calcium >10.5 mg/dL over a 2-year period.
RESULTS: Of 2.7 million patients, 54,198 (2%) had hypercalcemia (>10.5 mg/dL). In a 2-year sample of 7,269 patients, 1.3% (95 patients) had a recorded diagnosis of PHPT, and 0.3% (16 patients) had parathyroidectomy. Of the remaining patients, parathyroid hormone (PTH) values were recorded in 32% (2,337 patients). Of patients with PTH measured, 71% (1,662 patients) had PHPT (PTH > 30 pg/mL). Patients with calcium of 11.1–11.5 mg/dL were most likely to have PHPT (55%). Patients with calcium >12 mg/dL were most likely to have PTH measured (52%). Of hypercalcemic patients, 67% never had PTH obtained, 28% of whom were likely to have PHPT. It is estimated that 43% of hypercalcemic patients are likely to have PHPT. The estimated prevalence of PHPT in the general population is 0.86%.
CONCLUSION: PHPT is a more common disorder than previously documented. It is crucial to evaluate even mild hypercalcemia, because 43% of these patients have PHPT. PHPT is underdiagnosed and undertreated.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24383100     DOI: 10.1016/j.surg.2013.06.051

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  36 in total

1.  Occult urolithiasis in asymptomatic primary hyperparathyroidism.

Authors:  Yu-Kwang Donovan Tay; Minghao Liu; Leonardo Bandeira; Mariana Bucovsky; James A Lee; Shonni J Silverberg; Marcella D Walker
Journal:  Endocr Res       Date:  2018-02-05       Impact factor: 1.720

2.  US-guided microwave ablation for primary hyperparathyroidism: a safety and efficacy study.

Authors:  Bo-Qiang Fan; Xiao-Wei He; Huan-Huan Chen; Wei-Ming Zhang; Wei Tang
Journal:  Eur Radiol       Date:  2019-03-19       Impact factor: 5.315

3.  Use of Calcium and Parathyroid Hormone Nomogram to Distinguish Between Atypical Primary Hyperparathyroidism and Normal Patients.

Authors:  Olga A Lavryk; Allan E Siperstein
Journal:  World J Surg       Date:  2017-01       Impact factor: 3.352

Review 4.  Primary Hyperparathyroidism.

Authors:  John P Bilezikian
Journal:  J Clin Endocrinol Metab       Date:  2018-11-01       Impact factor: 5.958

5.  Thyroid and parathyroid tumours in patients submitted to X-ray scalp epilation during the tinea capitis eradication campaign in the North of Portugal (1950-1963).

Authors:  Paula Boaventura; Dina Pereira; Adélia Mendes; José Teixeira-Gomes; Manuel Sobrinho-Simões; Paula Soares
Journal:  Virchows Arch       Date:  2014-08-22       Impact factor: 4.064

6.  Improving diagnostic recognition of primary hyperparathyroidism with machine learning.

Authors:  Yash R Somnay; Mark Craven; Kelly L McCoy; Sally E Carty; Tracy S Wang; Caprice C Greenberg; David F Schneider
Journal:  Surgery       Date:  2016-12-15       Impact factor: 3.982

7.  Diagnostic accuracy of 3T magnetic resonance imaging in the preoperative localisation of parathyroid adenomas: comparison with ultrasound and 99mTc-sestamibi scans.

Authors:  Renato Argirò; Daniele Diacinti; Beatrice Sacconi; Angelo Iannarelli; Davide Diacinti; Cristiana Cipriani; Daniela Pisani; Elisabetta Romagnoli; Marco Biffoni; Cira Di Gioia; Jessica Pepe; Mario Bezzi; Claudio Letizia; Salvatore Minisola; Carlo Catalano
Journal:  Eur Radiol       Date:  2018-05-07       Impact factor: 5.315

Review 8.  Primary hyperparathyroidism.

Authors:  John P Bilezikian; Natalie E Cusano; Aliya A Khan; Jian-Min Liu; Claudio Marcocci; Francisco Bandeira
Journal:  Nat Rev Dis Primers       Date:  2016-05-19       Impact factor: 52.329

9.  Successful minimally invasive surgery for primary hyperparathyroidism: influence of preoperative imaging and intraoperative parathyroid hormone levels.

Authors:  Gaëtan-Romain Joliat; Nicolas Demartines; Luc Portmann; Ariane Boubaker; Maurice Matter
Journal:  Langenbecks Arch Surg       Date:  2015-11-21       Impact factor: 3.445

10.  CaPTHUS scoring model in primary hyperparathyroidism: can it eliminate the need for ioPTH testing?

Authors:  Dawn M Elfenbein; Sara Weber; David F Schneider; Rebecca S Sippel; Herbert Chen
Journal:  Ann Surg Oncol       Date:  2014-09-12       Impact factor: 5.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.